Jefferies Group LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 183 filers reported holding IMMUNOGEN INC in Q3 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2021$1,220,978
+1135.2%
215,340
+1335.6%
0.01%
+800.0%
Q2 2021$98,850
-43.2%
15,000
-76.6%
0.00%0.0%
Q1 2019$174,000
-47.4%
64,100
+83.1%
0.00%
-50.0%
Q3 2018$331,000
-36.8%
35,000
-35.1%
0.00%
-33.3%
Q2 2018$524,000
+638.0%
53,900
+439.0%
0.00%
Q2 2017$71,000
+610.0%
10,000
+1318.4%
0.00%
Q2 2015$10,000
-99.3%
705
-99.5%
0.00%
-100.0%
Q1 2015$1,397,000
-7.5%
156,114
-37.0%
0.01%
-11.1%
Q4 2014$1,511,000
+154.4%
247,841
+394.7%
0.01%
+80.0%
Q2 2014$594,000
-49.5%
50,103
-27.5%
0.01%
-58.3%
Q3 2013$1,176,00069,1000.01%
Other shareholders
IMMUNOGEN INC shareholders Q3 2017
NameSharesValueWeighting ↓
TWIN FOCUS CAPITAL PARTNERS, LLC 140,000$2,090,0002.48%
BB BIOTECH AG 3,165,816$47,266,0002.44%
SECTORAL ASSET MANAGEMENT INC 3,623,786$54,103,0002.22%
Lumbard & Kellner, LLC 81,225$1,192,0001.02%
Artal Group S.A. 1,300,000$19,409,0000.70%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 100,000$1,493,0000.48%
Rhenman & Partners Asset Management AB 73,702$1,100,0000.33%
PINNACLE ASSOCIATES LTD 883,647$13,193,0000.26%
FIRST TRUST ADVISORS LP 3,608,918$53,881,0000.24%
Granahan Investment Management 540,641$8,072,0000.22%
View complete list of IMMUNOGEN INC shareholders